Impact Factor
2.86
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.48
390 total citations
h5-index
22
h5 depth signal
Cited share
56.8%
155 of 273
Total citations
390
Citation footprint
Metric signal
1.26
External metric anchor
Self-citation
1.8%
7 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
India
985
United States
42
Indonesia
36
Iran
16
Uzbekistan
15
Citing Fields of Research
Mycobacterial Diseases
1,210
Lung Cancer
59
Healthcare Policy
40
Health Education & Remote Healthcare
37
Bacteriology
34
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,540
Articles tracked across the journal lifetime
Indexed publication set
273
155 cited publications
Last 12 months
198
16.5 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
India
985 citing publications
Leading citing field
Mycobacterial Diseases
1,210 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v54n1, Jan. 2007-
v54n1, Jan. 2007-
Research Focus & Classification
Indexed Subjects
Mycobacterial Diseases
Issuing & Sponsoring Bodies
Contributor
Tuberculosis Association of India
Broad Categories
Communicable Diseases
Mycobacterial Diseases
MeSH Descriptors
Tuberculosis
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1016/j.ijtb.2026.10.006
Open DOI
The effectiveness of community based social support for pulmonary TB patients: A systematic review
02
DOI 10.1016/j.ijtb.2026.10.005
Open DOI
Novel and emerging Anti-Tubercular Drugs: reshaping the future of tuberculosis pharmacotherapy
03
DOI 10.1016/j.ijtb.2026.10.004
Open DOI
Closing the diagnostic gap to interrupt transmission
04
DOI 10.1016/j.ijtb.2026.10.001
Open DOI
Pattern and radiological severity of post-tuberculosis lung disease: A prospective observational study
05
DOI 10.1016/j.ijtb.2026.10.003
Open DOI
Ending tuberculosis requires ending assumptions
06
07
08
09
DOI 10.1016/j.ijtb.2026.09.004
Open DOI
Isoniazid-induced high anion gap metabolic acidosis at therapeutic dose in a patient with tubercular meningitis
10
Bibliographical & Catalog Notes
Also issued online.